Toxicity and antidotal treatment by synthesized and optimized ferric(III) hexacyanoferrate(II) for thallium

Kumar, Vivek; Pathak, Dharam Pal; Sandal, Nidhi

doi:10.1186/s42269-023-01086-x

Bulletin of the National Research Centre

Table 3 Effect on haematological parameters during sub-acute toxicity study of (PB -1 and PB -2)

From: Toxicity and antidotal treatment by synthesized and optimized ferric(III) hexacyanoferrate(II) for thallium

Parameters	Male			Female
Parameters	Control	PB-1	PB-2	Control	PB-1	PB-2
WBC (10³µL)	7.460 ± 0.321	7.860 ± 0.288	7.920 ± 0.377	6.260 ± 0.555	6.360 ± 0.365	6.380 ± 0.389
RBC (10⁶µL)	8.740 ± 0.182	8.842 ± 0.118	8.800 ± 0.265	8.360 ± 0.336	8.580 ± 0.311	8.480 ± 0.303
HGB (g/dL)	14.660 ± 0.473	15.050 ± 0.432	15.090 ± 0.462	14.260 ± 0.416	14.540 ± 0.428	14.560 ± 0.343
HCT (%)	44.520 ± 1.397	44.120 ± 1.724	44.720 ± 1.547	43.420 ± 1.377	43.900 ± 1.342	43.620 ± 0.861
MCV (fL)	56.700 ± 1.350	57.500 ± 1.576	56.940 ± 1.083	56.920 ± 2.317	57.200 ± 2.690	57.080 ± 3.360
MCH (pg)	19.300 ± 0.652	19.520 ± 0.854	19.310 ± 1.007	19.030 ± 0.634	19.110 ± 0.537	19.100 ± 0.474
MCHC (g/dL)	33.720 ± 0.444	33.840 ± 0.591	33.840 ± 0.591	33.100 ± 1.122	32.760 ± 1.834	32.980 ± 1.665
PLT (103µL)	1221.000 ± 23.820	1217.000 ± 87.15	1217.000 ± 68.200	1179.000 ± 34.440	1177.000 ± 39.690	1175.000 ± 42.750
LYMPH (%)	71.600 ± 1.140	72.400 ± 1.517	71.800 ± 1.304	68.600 ± 2.702	69.400 ± 1.817	69.200 ± 2.490
MONO (%)	6.200 ± 0.837	6.600 ± 0.548	6.400 ± 0.894	5.200 ± 1.483	5.600 ± 1.140	5.400 ± 1.140
GR (%)	24.800 ± 1.920	25.400 ± 1.140	25.600 ± 1.140	23.400 ± 2.074	24.400 ± 2.074	24.000 ± 1.580
RDW	23.540 ± 0.994	24.040 ± 1.043	24.040 ± 1.043	13.500 ± 1.281	14.020 ± 1.180	14.060 ± 0.472
PCT	0.900 ± 0.044	0.944 ± 0.049	0.950 ± 0.037	0.736 ± 0.091	0.720 ± 0.106	0.718 ± 0.025
MPV (fL)	7.600 ± 0.224	7.740 ± 0.182	7.760 ± 0.207	7.780 ± 0.164	7.940 ± 0.230	7.800 ± 0.509
PDW (fL)	16.300 ± 0.692	16.820 ± 0.366	16.740 ± 0.323	15.580 ± 0.476	15.620 ± 0.487	15.640 ± 0.343

Back to article page